Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis

Annals of Surgery

Volumn 250, Issue 5, 2009, Pages 712-719

  Besselink, Marc G ^a   Van Santvoort, Hjalmar C ^a   Renooij, Willem ^a   De Smet, Martin B ^a   Boermeester, Marja A ^b   Fischer, Kathelijn ^a   Timmerman, Harro M ^a   Ahmed Ali, Usama ^a   Cirkel, Geert A ^a   Bollen, Thomas L ^c   Van Ramshorst, Bert ^d   Schaapherder, Alexander F ^e   Witteman, Ben J ^f   Ploeg, Rutger J ^g   Van Goor, Harry ^h   Van Laarhoven, Cornelis J ⁱ   Tan, Adriaan C ^j   Brink, Menno A ^k   Van Der Harst, Erwin ^l   Wahab, Peter J ^m   Van Eijck, Casper H ⁿ   Dejong, Cornelis H ^o   Van Erpecum, Karel J ^a   Akkermans, Louis M ^a   Gooszen, Hein G ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Departments of Radiology

^d ST ANTONIUS HOSPITAL   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f GELDERSE VALLEI HOSPITAL   (Netherlands)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ TweeSteden Hospital   (Netherlands)

^j CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^k MEANDER MEDICAL CENTER   (Netherlands)

^l Maasstad Hospital ^*  (Netherlands)

^m RIJNSTATE HOSPITAL   (Netherlands)

ⁿ ERASMUS MEDICAL CENTER   (Netherlands)

^o MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ECOLOGIC 641; FATTY ACID BINDING PROTEIN; MACROGOL; MACROGOL 4000; NITRIC OXIDE; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL TRANSLOCATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EXCRETION; FEMALE; HUMAN; INTESTINE BARRIER DYSFUNCTION; INTESTINE CELL; INTESTINE FUNCTION DISORDER; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PANCREAS NECROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE DISEASE; BACTEREMIA; BACTERIAL TRANSLOCATION; DOUBLE-BLIND METHOD; ENTEROCYTES; FATTY ACID-BINDING PROTEINS; HUMANS; INTESTINES; NITRIC OXIDE; PANCREATITIS; PERMEABILITY; POLYETHYLENE GLYCOLS; PROBIOTICS;

EID: 70449429434     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181bce5bd     Document Type: Article

References (30)

1. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128-2138.
2. Yadav D, Lowenfels AB. Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas. 2006;33:323-330.
3. Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101:2379-2400.
4. Beger HG, Rau B, Mayer J, et al. Natural course of acute pancreatitis. World J Surg. 1997;21:130-135.
5. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg. 1990;125:403-404.
6. Ockner RK, Manning JA. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J Clin Invest. 1974;54:326-338.
7. Kanda T, Fujii H, Tani T, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology. 1996;110:339-343.
8. Lieberman JM, Sacchettini J, Marks C, et al. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997;121:335-342.
9. Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotox-emia, organ failure, and mortality. J Gastrointest Surg. 1999;3:252-262.
10. Parlesak A, Bode JC, Bode C. Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol. Eur J Clin Chem Clin Biochem. 1994;32:813-820.
11. Rahman SH, Ammori BJ, Holmfield J, et al. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg. 2003;7:26-35.
12. Ammori BJ, Fitzgerald P, Hawkey P, et al. The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood. Pancreas. 2003;26:18-22.
13. Oudenhoven IM, Klaasen HL, Lapre JA, et al. Nitric oxide-derived urinary nitrate as a marker of intestinal bacterial translocation in rats. Gastroenterology. 1994; 107:47-53.
14. Rahman SH, Ammori BJ, Larvin M, et al. Increased nitric oxide excretion in patients with severe acute pancreatitis: evidence of an endotoxin mediated inflammatory response? Gut. 2003;52:270-274.
15. Llopis M, Antolin M, Guarner F, et al. Mucosal colonisation with Lactoba-cillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid. Gut. 2005;54:955-959.
16. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha-and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology. 2006;130:731-746.
17. Olah A, Belagyi T, Issekutz A, et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103-1107.
18. Olah A, Belagyi T, Poto L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology. 2007;54:590-594.
19. Besselink MG, Van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659.
20. Soeters PB. Probiotics: Did we go wrong, and if so, where? Clin Nutr. 2008;27:173-178.
21. Vogel G. Clinical trials. Deaths prompt a review of experimental probiotic therapy. Science. 2008;319:557.
22. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg. 1993;128:586-590.
23. Watson AJ, Chu S, Sieck L, et al. Epithelial barrier function in vivo is sustained despite gaps in epithelial layers. Gastroenterology. 2005;129:902-912.
24. Rayes N, Seehofer D, Theruvath T, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduo-denectomy: a randomized, double-blind trial. Ann Surg. 2007;246:36-41.
25. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706-714.
26. Van Santvoort HC, Besselink MG, Timmerman HM, et al. Probiotics in surgery. Surgery. 2008;143:1-7.
27. Andersson R, Wang X, Ihse I. The influence of abdominal sepsis on acute pancreatitis in rats: a study on mortality, permeability, arterial pressure, and intestinal blood flow. Pancreas. 1995;11:365-373.
28. Nazli A, Yang PC, Jury J, et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol. 2004;164:947-957.
29. Petrov MS, Van Santvoort HC, Besselink MG, et al. Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg. 2008;143:1111-1117.
30. Karakan T, Ergun M, Dogan I, et al. Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study. World J Gastroenterol. 2007;13:2733-2737.